The rationale for establishing low-toxicity smokeless nicotine product polici...TobaccoFindings
The document discusses tobacco harm reduction through the use of low-toxicity smokeless tobacco products like Swedish snus. It summarizes evidence from Swedish population studies that finds little risk of snus leading to smoking, strengthening nicotine addiction, or weakening smokers' efforts to quit. The evidence suggests that snus use can substantially reduce tobacco-related disease risk and that some smokers who switch to snus do subsequently quit nicotine altogether. There is little scientific evidence to support arguments against tobacco harm reduction and good evidence to reject such arguments.
New tobacco and nicotine products such as e-cigarettes, waterpipes, and smokeless tobacco are emerging on the market. Waterpipe smoking appears to be more harmful than traditional cigarettes due to higher levels of toxic compounds. E-cigarettes deliver lower levels of nicotine but may help with smoking cessation to some extent. Swedish snus has a modest mortality risk increase over non-users but its use in Sweden has demonstrated public health benefits as an aid for smoking cessation. Regulating all smokeless tobacco products according to WHO guidelines on toxicant limits could benefit public health.
The document discusses strategies for reducing tobacco harm in New Zealand. It agrees that increasing options for smokers who find quitting difficult is urgent. However, it argues that more can be done with existing nicotine replacement therapies (NRT) before introducing new tobacco products like Swedish snus. Specifically, the document suggests exploring longer-term NRT treatment and faster-acting NRT products first to help more smokers reduce harm from tobacco use. Introducing snus raises concerns about evidence of effectiveness, impacts on indigenous Māori populations, ties to the tobacco industry, and potential health risks from tobacco-specific nitrosamines.
1) Tobacco was introduced to Europe in the 16th century and there are now over 1 billion smokers worldwide. Smoking causes over 8 million deaths per year projected to rise to 12% of all deaths by 2020.
2) Tobacco smoke contains over 500 compounds including nicotine and tars. Cigarette smoke is acidic whereas cigar and pipe smoke is alkaline, affecting how nicotine is absorbed and the associated health risks.
3) Smoking causes diseases of the cardiovascular and respiratory systems as well as various cancers. It is estimated smoking will cause over 450 million deaths between 2000-2050, around half between ages 30-69.
The rationale for establishing low-toxicity smokeless nicotine product polici...TobaccoFindings
The document discusses tobacco harm reduction through the use of low-toxicity smokeless tobacco products like Swedish snus. It summarizes evidence from Swedish population studies that finds little risk of snus leading to smoking, strengthening nicotine addiction, or weakening smokers' efforts to quit. The evidence suggests that snus use can substantially reduce tobacco-related disease risk and that some smokers who switch to snus do subsequently quit nicotine altogether. There is little scientific evidence to support arguments against tobacco harm reduction and good evidence to reject such arguments.
New tobacco and nicotine products such as e-cigarettes, waterpipes, and smokeless tobacco are emerging on the market. Waterpipe smoking appears to be more harmful than traditional cigarettes due to higher levels of toxic compounds. E-cigarettes deliver lower levels of nicotine but may help with smoking cessation to some extent. Swedish snus has a modest mortality risk increase over non-users but its use in Sweden has demonstrated public health benefits as an aid for smoking cessation. Regulating all smokeless tobacco products according to WHO guidelines on toxicant limits could benefit public health.
The document discusses strategies for reducing tobacco harm in New Zealand. It agrees that increasing options for smokers who find quitting difficult is urgent. However, it argues that more can be done with existing nicotine replacement therapies (NRT) before introducing new tobacco products like Swedish snus. Specifically, the document suggests exploring longer-term NRT treatment and faster-acting NRT products first to help more smokers reduce harm from tobacco use. Introducing snus raises concerns about evidence of effectiveness, impacts on indigenous Māori populations, ties to the tobacco industry, and potential health risks from tobacco-specific nitrosamines.
1) Tobacco was introduced to Europe in the 16th century and there are now over 1 billion smokers worldwide. Smoking causes over 8 million deaths per year projected to rise to 12% of all deaths by 2020.
2) Tobacco smoke contains over 500 compounds including nicotine and tars. Cigarette smoke is acidic whereas cigar and pipe smoke is alkaline, affecting how nicotine is absorbed and the associated health risks.
3) Smoking causes diseases of the cardiovascular and respiratory systems as well as various cancers. It is estimated smoking will cause over 450 million deaths between 2000-2050, around half between ages 30-69.
Tobacco Harm Reduction by Somchai Bovornkitti* in Crimson Publishers: Telemedicine and e-Health open access journals
Cigarette smoke contain approximately 250 different chemicals known to be harmful to human health. Thousands of harmful chemical substances produce by the combustion of tobacco. The health impacts such as cancer and chronic lung disease are not only associated with smokers but also people who are exposed to secondhand smoke. Tobacco Harm Reduction is a concept to minimize the impacts of tobacco on the individual and on society at large. A key component of this strategy is using alternative source of nicotine as a substitute to tobacco cigarettes. Electronic cigarette and heated tobacco are alternatives that might have potential in reduce harm from smokes. This paper elaborates on available research associated with electronic cigarette and heated tobacco with harm reduction and risk perspective.
https://crimsonpublishers.com/tteh/fulltext/TTEH.000522.php
For more Open access journals in Crimson Publishers
Please click on: https://crimsonpublishers.com/
For more Articles on Telemedicine and e-Health open access journals
please click on link: https://crimsonpublishers.com/tteh/index.php
Please follow the below link for our LinkedIn page
https://www.linkedin.com/company/crimsonpublishers
The role of harm reduction in tobacco controlTobaccoFindings
The document discusses the role of harm reduction in tobacco control. It argues that for current tobacco users who cannot quit, switching to a nicotine product that is markedly less harmful than cigarettes, such as nicotine replacement therapy or low-nitrosamine smokeless tobacco, can significantly reduce health risks compared to continuing smoking. While prevention and smoking cessation efforts are important, harm reduction strategies are also needed to help smokers unable or unwilling to quit nicotine use altogether. Regulating alternative nicotine products to ensure they are much safer than cigarettes can achieve public health benefits as part of a comprehensive approach to tobacco control.
How e cigarettes should be regulated in uk ecig summitMatt Stan
This document summarizes a presentation on proposed changes to e-cigarette regulation in the UK and EU. It discusses the current state of e-cigarette use and harm reduction, NICE guidance supporting harm reduction approaches, and the ongoing revision of the EU Tobacco Products Directive to determine regulations for e-cigarettes. Key points addressed include evidence that cutting down smoking provides little health benefit on its own but may with nicotine replacement therapy, and NICE's recommendation that licensed nicotine products are less harmful than tobacco for harm reduction.
Proposed Changes to How E-Cigarettes Are Regulated - Prof. Linda BauldLindsay Fox
Proposed changes to how e-cigarettes are regulated: UK and EU context
Slides from Prof. Linda Bauld's presentation at the E-Cigarette Summit, London November 12, 2013.
Full summary of the E-Cigarette Summit: http://ecigarettereviewed.com/e-cigarette-summit-london-summary
- The document discusses nicotine testing methods and their use in various contexts like insurance, employment, schools, and research. It also covers nicotine metabolism and the differences between nicotine and its metabolite cotinine.
- The Nano-Check Rapid Nicotine Test is described as an immunoassay that detects cotinine in urine at cutoff levels of 200ng/ml or 500ng/ml to determine tobacco use. It provides results in 5-10 minutes and is intended for professional use.
- The test works by detecting cotinine in a urine sample via monoclonal antibodies on a test strip, with positive or negative results depending on whether or not a test line appears within the timeframe.
E-cigarettes provide an alternative to nicotine delivery through vapor rather than smoke. While they may be less harmful than conventional cigarettes, there are still health risks and unknown long-term effects. The document discusses both sides of the debate around e-cigarettes. Some view them as a harm reduction tool that can help smokers quit, while others are concerned they could renormalize smoking behaviors and expose users to carcinogens. Long-term studies are still needed to fully understand the safety profile of e-cigarettes and their impacts on public health.
Chemistry and Effect of Nicotine, Smoking Pollution and Stopping it under Sec...ijtsrd
“Chemistry,” includes a brief description of technologies used by cigarette manufacturers in a limited number of cigarette brands marketed as “reduced exposure” or “lower yield” products. These commercial products have not been met with widespread consumer acceptance. The following section, “Biomarkers,” focuses on the manufactured tobacco burning cigarette consumed by the majority of smokers in the United States and elsewhere. The review on “Chemistry” describes the chemical components of cigarette smoke and addresses aspects of product design that alter the components of cigarette smoke and factors affecting delivery of smoke to the smoker. In most cases, the data reported for chemical levels in mainstream smoke were derived under standard smoking conditions described by the U.S. Federal Trade Commission FTC and the International Organization for Standardization ISO . These standard conditions are puff volume of 35 milliliters mL , two second puff duration, one minute puff frequency, and butt length defined as either 23 millimeters mm for nonfilter cigarettes or the length of the filter overwrap paper plus 3 mm. When alternative smoking regimens are used, levels of potentially harmful substances in smoke emissions usually differ from those measured under standard conditions. For more details, see “Delivery of Chemical Constituents into Tobacco Smoke” later in this chapter. When people smoke, they do not use the puff volume and puff frequency programmed into smoking machines, and smoking habits vary significantly from person to person and cigarette to cigarette. Consequently, actual exposures to and doses of components of smoke cannot be derived from values obtained with machine smoking. Cigarette smoke is a complex mixture of chemical compounds that are bound to aerosol particles or are free in the gas phase. Chemical compounds in tobacco can be distilled into smoke or can react to form other constituents that are then distilled to smoke. Researchers have estimated that cigarette smoke has 7,357 chemical compounds from many different classes .In assessing the nature of tobacco smoke, scientists must consider chemical composition, concentrations of components, particle size, and particle charge. These characteristics vary with the cigarette design and the chemical nature of the product.Scientists suggested an approach to identify the chemical components in tobacco smoke with the greatest potential for toxic effects. They considered the risk for cancer, cardiovascular disease, and heart disease. Using this approach, these investigators found that 1,3 butadiene presented by far the most significant cancer risk acrolein and acetaldehyde had the greatest potential to be respiratory irritants and cyanide, arsenic, and the cresols were the primary sources of cardiovascular risk. Other chemical classes of concern include other metals, N nitrosamines, and polycyclic aromatic hydrocarbons PAHs . This evaluation, along with the Hoffmann list of biol
Effects of alternative nicotine delivery systems on cigarette consumption and...Clive Bates
This document summarizes a presentation on the effects of alternative nicotine delivery systems like e-cigarettes on cigarette consumption and smoking prevalence. It discusses data showing declines in smoking rates in countries where vaping products are widely available and accepted like the US, UK, and Sweden. Studies suggest vaping helps increase smoking cessation rates at a population level. The rise of Juul products in the US may have accelerated declines in youth smoking rates there in recent years. Countries in Asia have also seen significant drops in cigarette sales as heat-not-burn tobacco and vaping products gain popularity. However, public health attitudes can influence how quickly reduced risk alternatives are adopted.
An Experimental Method to Determine the Concentration of Nicotine in Exhaled ...Fontem Ventures
- An experimental method was presented to determine the concentration of nicotine in exhaled breath after using e-cigarettes and the nicotine retention rate.
- Three experienced e-cigarette users vaped e-cigarettes containing different nicotine concentrations while a smoking topography analyzer recorded puff volume and duration. This allowed determining the nicotine concentration inhaled per puff.
- A PTR-MS instrument then measured nicotine in exhaled breath, allowing calculation of the retention rate by comparing to the inhaled nicotine concentration. Over 99% of nicotine was retained when inhaled and 86% when held in the mouth. Exhaled nicotine concentrations were low (1.8-1786 ppb
NYU College of Global Health - E-cigarette seminar - New YorkClive Bates
E-Cigarettes: The Tectonic Shift in Nicotine and Tobacco Consumption: Opportunity or Threat to Saving Lives?
Clive Bates
Friday, October 19, 2018
NYU School of Law, Greenberg Lounge
40 Washington Square South, New York, New York
This document discusses electronic cigarettes (ECs) and whether they are safer than combustible cigarettes. It summarizes that while ECs may expose users to fewer harmful chemicals than smoking, the long-term safety of ECs is still unknown. Studies have found potentially harmful chemicals in EC vapor, but in much lower amounts than in cigarette smoke. The regulation of ECs is also debated, as stricter rules may discourage innovation but make the products less appealing to youth and non-smokers. The evidence that ECs help smokers quit is also limited and inconclusive. More research is still needed to understand the public health impact of ECs.
Smoking involves burning a substance and inhaling the smoke, which is harmful. Cigarette smoke contains over 4,000 chemicals including 43 cancer-causing compounds and 400 toxins like tar and nicotine. Nicotine is highly addictive and acts as both a stimulant and depressant in the brain. Smoking causes nearly 500,000 deaths annually in the US from cancers, heart disease, and strokes. While e-cigarettes were created to potentially reduce harm, they still deliver addictive nicotine and many contain other toxins. Quitting smoking improves health by reducing cancer risks and repairing damage to the lungs and blood vessels over time.
This study compared the effects of cigarette smoke, e-cigarette vapor, and pure nicotine on cell viability using HeLa cells. Various concentrations of smoke and vapor condensates collected from a mechanical smoking system were applied to cells for 24 hours. An MTT assay then measured cell viability. Cigarette smoke exposure resulted in lower viability than e-cigarette vapor, but higher than pure nicotine. The results provide insight into the acute toxicity of these substances and whether e-cigarettes may be less harmful than cigarettes.
Dr Konstantinos Farsalinos - E-Cigarette Summit 2014Neil Mclaren
Dr. Konstantinos Farsalinos presented research on the safety of electronic cigarettes. He discussed the basic ingredients of e-cigarettes and found that glycerol, propylene glycol, and flavors were generally safe, but thermal degradation can produce low levels of toxic aldehydes. Flavorings were also found to potentially cause cytotoxicity depending on the specific flavor and amount used. Heavy metals in e-cigarettes were found to be at levels below acceptable daily intake limits for inhalation medications. Overall, e-cigarettes were estimated to pose around 5% of the risk of smoking, and promoting their use could avert thousands of smoking-related deaths each year by providing an alternative to smoking.
Tobacco Harm Reduction - an introductionClive Bates
This document provides an introduction to tobacco harm reduction and alternative nicotine products such as e-cigarettes. It summarizes statements from public health organizations that find e-cigarettes to be much less harmful than combustible cigarettes. Research shows e-cigarettes help smokers quit at the population level and are effective cessation tools. The document argues for risk-proportionate regulation and taxation of nicotine products to incentivize smokers to switch to less harmful options and further reduce smoking rates.
Steam instead of smoke - that sounds good at first. But researchers from the \UK warn of the long-term effects of e-cigarettes. Yet they have yet to be explored. We know that so far.
Perception of health status among different groups of tobacco users in SwedenTobaccoFindings
This document summarizes a study comparing self-reported health perceptions among different groups of tobacco users in Sweden. The study found that:
1) Current daily smokers reported poorer satisfaction with their health, life, and higher numbers of sick days than other groups.
2) Daily snus users, both with and without a history of smoking, reported health perceptions similar to non-users and better than current smokers.
3) Former smokers who now use snus daily reported better mental health and life satisfaction than current smokers.
The results suggest that smoking impairs perceived health while switching from smoking to snus may improve it.
Tobacco Harm Reduction by Somchai Bovornkitti* in Crimson Publishers: Telemedicine and e-Health open access journals
Cigarette smoke contain approximately 250 different chemicals known to be harmful to human health. Thousands of harmful chemical substances produce by the combustion of tobacco. The health impacts such as cancer and chronic lung disease are not only associated with smokers but also people who are exposed to secondhand smoke. Tobacco Harm Reduction is a concept to minimize the impacts of tobacco on the individual and on society at large. A key component of this strategy is using alternative source of nicotine as a substitute to tobacco cigarettes. Electronic cigarette and heated tobacco are alternatives that might have potential in reduce harm from smokes. This paper elaborates on available research associated with electronic cigarette and heated tobacco with harm reduction and risk perspective.
https://crimsonpublishers.com/tteh/fulltext/TTEH.000522.php
For more Open access journals in Crimson Publishers
Please click on: https://crimsonpublishers.com/
For more Articles on Telemedicine and e-Health open access journals
please click on link: https://crimsonpublishers.com/tteh/index.php
Please follow the below link for our LinkedIn page
https://www.linkedin.com/company/crimsonpublishers
The role of harm reduction in tobacco controlTobaccoFindings
The document discusses the role of harm reduction in tobacco control. It argues that for current tobacco users who cannot quit, switching to a nicotine product that is markedly less harmful than cigarettes, such as nicotine replacement therapy or low-nitrosamine smokeless tobacco, can significantly reduce health risks compared to continuing smoking. While prevention and smoking cessation efforts are important, harm reduction strategies are also needed to help smokers unable or unwilling to quit nicotine use altogether. Regulating alternative nicotine products to ensure they are much safer than cigarettes can achieve public health benefits as part of a comprehensive approach to tobacco control.
How e cigarettes should be regulated in uk ecig summitMatt Stan
This document summarizes a presentation on proposed changes to e-cigarette regulation in the UK and EU. It discusses the current state of e-cigarette use and harm reduction, NICE guidance supporting harm reduction approaches, and the ongoing revision of the EU Tobacco Products Directive to determine regulations for e-cigarettes. Key points addressed include evidence that cutting down smoking provides little health benefit on its own but may with nicotine replacement therapy, and NICE's recommendation that licensed nicotine products are less harmful than tobacco for harm reduction.
Proposed Changes to How E-Cigarettes Are Regulated - Prof. Linda BauldLindsay Fox
Proposed changes to how e-cigarettes are regulated: UK and EU context
Slides from Prof. Linda Bauld's presentation at the E-Cigarette Summit, London November 12, 2013.
Full summary of the E-Cigarette Summit: http://ecigarettereviewed.com/e-cigarette-summit-london-summary
- The document discusses nicotine testing methods and their use in various contexts like insurance, employment, schools, and research. It also covers nicotine metabolism and the differences between nicotine and its metabolite cotinine.
- The Nano-Check Rapid Nicotine Test is described as an immunoassay that detects cotinine in urine at cutoff levels of 200ng/ml or 500ng/ml to determine tobacco use. It provides results in 5-10 minutes and is intended for professional use.
- The test works by detecting cotinine in a urine sample via monoclonal antibodies on a test strip, with positive or negative results depending on whether or not a test line appears within the timeframe.
E-cigarettes provide an alternative to nicotine delivery through vapor rather than smoke. While they may be less harmful than conventional cigarettes, there are still health risks and unknown long-term effects. The document discusses both sides of the debate around e-cigarettes. Some view them as a harm reduction tool that can help smokers quit, while others are concerned they could renormalize smoking behaviors and expose users to carcinogens. Long-term studies are still needed to fully understand the safety profile of e-cigarettes and their impacts on public health.
Chemistry and Effect of Nicotine, Smoking Pollution and Stopping it under Sec...ijtsrd
“Chemistry,” includes a brief description of technologies used by cigarette manufacturers in a limited number of cigarette brands marketed as “reduced exposure” or “lower yield” products. These commercial products have not been met with widespread consumer acceptance. The following section, “Biomarkers,” focuses on the manufactured tobacco burning cigarette consumed by the majority of smokers in the United States and elsewhere. The review on “Chemistry” describes the chemical components of cigarette smoke and addresses aspects of product design that alter the components of cigarette smoke and factors affecting delivery of smoke to the smoker. In most cases, the data reported for chemical levels in mainstream smoke were derived under standard smoking conditions described by the U.S. Federal Trade Commission FTC and the International Organization for Standardization ISO . These standard conditions are puff volume of 35 milliliters mL , two second puff duration, one minute puff frequency, and butt length defined as either 23 millimeters mm for nonfilter cigarettes or the length of the filter overwrap paper plus 3 mm. When alternative smoking regimens are used, levels of potentially harmful substances in smoke emissions usually differ from those measured under standard conditions. For more details, see “Delivery of Chemical Constituents into Tobacco Smoke” later in this chapter. When people smoke, they do not use the puff volume and puff frequency programmed into smoking machines, and smoking habits vary significantly from person to person and cigarette to cigarette. Consequently, actual exposures to and doses of components of smoke cannot be derived from values obtained with machine smoking. Cigarette smoke is a complex mixture of chemical compounds that are bound to aerosol particles or are free in the gas phase. Chemical compounds in tobacco can be distilled into smoke or can react to form other constituents that are then distilled to smoke. Researchers have estimated that cigarette smoke has 7,357 chemical compounds from many different classes .In assessing the nature of tobacco smoke, scientists must consider chemical composition, concentrations of components, particle size, and particle charge. These characteristics vary with the cigarette design and the chemical nature of the product.Scientists suggested an approach to identify the chemical components in tobacco smoke with the greatest potential for toxic effects. They considered the risk for cancer, cardiovascular disease, and heart disease. Using this approach, these investigators found that 1,3 butadiene presented by far the most significant cancer risk acrolein and acetaldehyde had the greatest potential to be respiratory irritants and cyanide, arsenic, and the cresols were the primary sources of cardiovascular risk. Other chemical classes of concern include other metals, N nitrosamines, and polycyclic aromatic hydrocarbons PAHs . This evaluation, along with the Hoffmann list of biol
Effects of alternative nicotine delivery systems on cigarette consumption and...Clive Bates
This document summarizes a presentation on the effects of alternative nicotine delivery systems like e-cigarettes on cigarette consumption and smoking prevalence. It discusses data showing declines in smoking rates in countries where vaping products are widely available and accepted like the US, UK, and Sweden. Studies suggest vaping helps increase smoking cessation rates at a population level. The rise of Juul products in the US may have accelerated declines in youth smoking rates there in recent years. Countries in Asia have also seen significant drops in cigarette sales as heat-not-burn tobacco and vaping products gain popularity. However, public health attitudes can influence how quickly reduced risk alternatives are adopted.
An Experimental Method to Determine the Concentration of Nicotine in Exhaled ...Fontem Ventures
- An experimental method was presented to determine the concentration of nicotine in exhaled breath after using e-cigarettes and the nicotine retention rate.
- Three experienced e-cigarette users vaped e-cigarettes containing different nicotine concentrations while a smoking topography analyzer recorded puff volume and duration. This allowed determining the nicotine concentration inhaled per puff.
- A PTR-MS instrument then measured nicotine in exhaled breath, allowing calculation of the retention rate by comparing to the inhaled nicotine concentration. Over 99% of nicotine was retained when inhaled and 86% when held in the mouth. Exhaled nicotine concentrations were low (1.8-1786 ppb
NYU College of Global Health - E-cigarette seminar - New YorkClive Bates
E-Cigarettes: The Tectonic Shift in Nicotine and Tobacco Consumption: Opportunity or Threat to Saving Lives?
Clive Bates
Friday, October 19, 2018
NYU School of Law, Greenberg Lounge
40 Washington Square South, New York, New York
This document discusses electronic cigarettes (ECs) and whether they are safer than combustible cigarettes. It summarizes that while ECs may expose users to fewer harmful chemicals than smoking, the long-term safety of ECs is still unknown. Studies have found potentially harmful chemicals in EC vapor, but in much lower amounts than in cigarette smoke. The regulation of ECs is also debated, as stricter rules may discourage innovation but make the products less appealing to youth and non-smokers. The evidence that ECs help smokers quit is also limited and inconclusive. More research is still needed to understand the public health impact of ECs.
Smoking involves burning a substance and inhaling the smoke, which is harmful. Cigarette smoke contains over 4,000 chemicals including 43 cancer-causing compounds and 400 toxins like tar and nicotine. Nicotine is highly addictive and acts as both a stimulant and depressant in the brain. Smoking causes nearly 500,000 deaths annually in the US from cancers, heart disease, and strokes. While e-cigarettes were created to potentially reduce harm, they still deliver addictive nicotine and many contain other toxins. Quitting smoking improves health by reducing cancer risks and repairing damage to the lungs and blood vessels over time.
This study compared the effects of cigarette smoke, e-cigarette vapor, and pure nicotine on cell viability using HeLa cells. Various concentrations of smoke and vapor condensates collected from a mechanical smoking system were applied to cells for 24 hours. An MTT assay then measured cell viability. Cigarette smoke exposure resulted in lower viability than e-cigarette vapor, but higher than pure nicotine. The results provide insight into the acute toxicity of these substances and whether e-cigarettes may be less harmful than cigarettes.
Dr Konstantinos Farsalinos - E-Cigarette Summit 2014Neil Mclaren
Dr. Konstantinos Farsalinos presented research on the safety of electronic cigarettes. He discussed the basic ingredients of e-cigarettes and found that glycerol, propylene glycol, and flavors were generally safe, but thermal degradation can produce low levels of toxic aldehydes. Flavorings were also found to potentially cause cytotoxicity depending on the specific flavor and amount used. Heavy metals in e-cigarettes were found to be at levels below acceptable daily intake limits for inhalation medications. Overall, e-cigarettes were estimated to pose around 5% of the risk of smoking, and promoting their use could avert thousands of smoking-related deaths each year by providing an alternative to smoking.
Tobacco Harm Reduction - an introductionClive Bates
This document provides an introduction to tobacco harm reduction and alternative nicotine products such as e-cigarettes. It summarizes statements from public health organizations that find e-cigarettes to be much less harmful than combustible cigarettes. Research shows e-cigarettes help smokers quit at the population level and are effective cessation tools. The document argues for risk-proportionate regulation and taxation of nicotine products to incentivize smokers to switch to less harmful options and further reduce smoking rates.
Steam instead of smoke - that sounds good at first. But researchers from the \UK warn of the long-term effects of e-cigarettes. Yet they have yet to be explored. We know that so far.
Similar to Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies (20)
Perception of health status among different groups of tobacco users in SwedenTobaccoFindings
This document summarizes a study comparing self-reported health perceptions among different groups of tobacco users in Sweden. The study found that:
1) Current daily smokers reported poorer satisfaction with their health, life, and higher numbers of sick days than other groups.
2) Daily snus users, both with and without a history of smoking, reported health perceptions similar to non-users and better than current smokers.
3) Former smokers who now use snus daily reported better mental health and life satisfaction than current smokers.
The results suggest that smoking impairs perceived health while switching from smoking to snus may improve it.
Snus as a Substitution for Smoking: The Swedish ExperienceTobaccoFindings
The document summarizes a study on tobacco use in Sweden. It finds that among males, use of snus (a form of smokeless tobacco) is more common than smoking, but less common among females. Snus seems to reduce smoking initiation and increase smoking cessation rates. The study shows snus is an effective smoking cessation aid commonly used by males in Sweden.
The document discusses statistics on tobacco-related deaths from various WHO regions in 1998. It then discusses the percentage of total deaths attributable to tobacco use in different regions in 1990 and projections for 2020. The document also discusses why people smoke and maintain smoking habits, signs of nicotine addiction, classification of tobacco use disorders, and different intervention strategies to reduce tobacco-related harm including decreasing uptake, increasing cessation, and exploring potentially less harmful tobacco products.
Regulation of tobacco ingredients for largest possible reduction of health risksTobaccoFindings
Oral presentation by Lars Ramström at Workshop on tobacco ingredients, National Institute for Public Health and the Environment, Bilthoven, The Netherlands, 30 and 31 October 2003
Meaningful public education by labelling on tobacco packages: Some elements o...TobaccoFindings
Information provided on tobacco packages should clarify that:
1. A smoker's nicotine intake from cigarettes varies widely based on how they smoke and depends on their personal nicotine needs, not machine-measured yields.
2. Intake of other harmful substances depends on the brand-specific ratio of each substance to nicotine.
3. Health risk information should make clear that nicotine itself poses little risk, while combustion products in smoked tobacco are highly dangerous, and nicotine replacement therapies and smokeless tobacco are much less risky than smoking.
Allopurinol, a uric acid synthesis inhibitor acts by inhibiting Xanthine oxidase competitively as well as non- competitively, Whereas Oxypurinol is a non-competitive inhibitor of xanthine oxidase.
Can Traditional Chinese Medicine Treat Blocked Fallopian Tubes.pptxFFragrant
There are many traditional Chinese medicine therapies to treat blocked fallopian tubes. And herbal medicine Fuyan Pill is one of the more effective choices.
CLASSIFICATION OF H1 ANTIHISTAMINICS-
FIRST GENERATION ANTIHISTAMINICS-
1)HIGHLY SEDATIVE-DIPHENHYDRAMINE,DIMENHYDRINATE,PROMETHAZINE,HYDROXYZINE 2)MODERATELY SEDATIVE- PHENARIMINE,CYPROHEPTADINE, MECLIZINE,CINNARIZINE
3)MILD SEDATIVE-CHLORPHENIRAMINE,DEXCHLORPHENIRAMINE
TRIPROLIDINE,CLEMASTINE
SECOND GENERATION ANTIHISTAMINICS-FEXOFENADINE,
LORATADINE,DESLORATADINE,CETIRIZINE,LEVOCETIRIZINE,
AZELASTINE,MIZOLASTINE,EBASTINE,RUPATADINE. Mechanism of action of 2nd generation antihistaminics-
These drugs competitively antagonize actions of
histamine at the H1 receptors.
Pharmacological actions-
Antagonism of histamine-The H1 antagonists effectively block histamine induced bronchoconstriction, contraction of intestinal and other smooth muscle and triple response especially wheal, flare and itch. Constriction of larger blood vessel by histamine is also antagonized.
2) Antiallergic actions-Many manifestations of immediate hypersensitivity (type I reactions)are suppressed. Urticaria, itching and angioedema are well controlled.3) CNS action-The older antihistamines produce variable degree of CNS depression.But in case of 2nd gen antihistaminics there is less CNS depressant property as these cross BBB to significantly lesser extent.
4) Anticholinergic action- many H1 blockers
in addition antagonize muscarinic actions of ACh. BUT IN 2ND gen histaminics there is Higher H1 selectivitiy : no anticholinergic side effects
Storyboard on Acne-Innovative Learning-M. pharm. (2nd sem.) CosmeticsMuskanShingari
Acne is a common skin condition that occurs when hair follicles become clogged with oil and dead skin cells. It typically manifests as pimples, blackheads, or whiteheads, often on the face, chest, shoulders, or back. Acne can range from mild to severe and may cause emotional distress and scarring in some cases.
**Causes:**
1. **Excess Oil Production:** Hormonal changes during adolescence or certain times in adulthood can increase sebum (oil) production, leading to clogged pores.
2. **Clogged Pores:** When dead skin cells and oil block hair follicles, bacteria (usually Propionibacterium acnes) can thrive, causing inflammation and acne lesions.
3. **Hormonal Factors:** Fluctuations in hormone levels, such as during puberty, menstrual cycles, pregnancy, or certain medical conditions, can contribute to acne.
4. **Genetics:** A family history of acne can increase the likelihood of developing the condition.
**Types of Acne:**
- **Whiteheads:** Closed plugged pores.
- **Blackheads:** Open plugged pores with a dark surface.
- **Papules:** Small red, tender bumps.
- **Pustules:** Pimples with pus at their tips.
- **Nodules:** Large, solid, painful lumps beneath the surface.
- **Cysts:** Painful, pus-filled lumps beneath the surface that can cause scarring.
**Treatment:**
Treatment depends on the severity and type of acne but may include:
- **Topical Treatments:** Such as benzoyl peroxide, salicylic acid, or retinoids to reduce bacteria and unclog pores.
- **Oral Medications:** Antibiotics or oral contraceptives for hormonal acne.
- **Procedures:** Such as chemical peels, extraction of comedones, or light therapy for more severe cases.
**Prevention and Management:**
- **Cleanse:** Regularly wash skin with a gentle cleanser.
- **Moisturize:** Use non-comedogenic moisturizers to keep skin hydrated without clogging pores.
- **Avoid Irritants:** Such as harsh cosmetics or excessive scrubbing.
- **Sun Protection:** Use sunscreen to prevent exacerbation of acne scars and inflammation.
Acne treatment can take time, and consistency in skincare routines and treatments is crucial. Consulting a dermatologist can help tailor a treatment plan that suits individual needs and reduces the risk of scarring or long-term skin damage.
This presentation gives information on the pharmacology of Prostaglandins, Thromboxanes and Leukotrienes i.e. Eicosanoids. Eicosanoids are signaling molecules derived from polyunsaturated fatty acids like arachidonic acid. They are involved in complex control over inflammation, immunity, and the central nervous system. Eicosanoids are synthesized through the enzymatic oxidation of fatty acids by cyclooxygenase and lipoxygenase enzymes. They have short half-lives and act locally through autocrine and paracrine signaling.
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
As the world population is aging, Health tourism has become vitally important and will be increased day by day. Because
of the availability of quality health services and more favorable prices as well as to shorten the waiting list for medical
services regionally and internationally. There are some aspects of managing and doing marketing activities in order for
medical tourism to be feasible, in a region called as clustering in a region with main stakeholders groups includes Health
providers, Tourism cluster, etc. There are some related and affecting factors to be considered for the feasibility of medical
tourism within this study such as competitiveness, clustering, Entrepreneurship, SMEs. One of the growth phenomenon
is Health tourism in the city of Izmir and Turkey. The model of five competitive forces of Porter and The Diamond model
that is an economical model that shows the four main factors that affect the competitiveness of a nation and its industries
in this study. The short literature of medical tourism and regional clustering have been mentioned.
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
The Children are very vulnerable to get affected with respiratory disease.
In our country, the respiratory Disease conditions are consider as major cause for mortality and Morbidity in Child.
Storyboard on Skin- Innovative Learning (M-pharm) 2nd sem. (Cosmetics)MuskanShingari
Skin is the largest organ of the human body, serving crucial functions that include protection, sensation, regulation, and synthesis. Structurally, it consists of three main layers: the epidermis, dermis, and hypodermis (subcutaneous layer).
1. **Epidermis**: The outermost layer primarily composed of epithelial cells called keratinocytes. It provides a protective barrier against environmental factors, pathogens, and UV radiation.
2. **Dermis**: Located beneath the epidermis, the dermis contains connective tissue, blood vessels, hair follicles, and sweat glands. It plays a vital role in supporting and nourishing the epidermis, regulating body temperature, and housing sensory receptors for touch, pressure, temperature, and pain.
3. **Hypodermis**: Also known as the subcutaneous layer, it consists of fat and connective tissue that anchors the skin to underlying structures like muscles and bones. It provides insulation, cushioning, and energy storage.
Skin performs essential functions such as regulating body temperature through sweat production and blood flow control, synthesizing vitamin D when exposed to sunlight, and serving as a sensory interface with the external environment.
Maintaining skin health is crucial for overall well-being, involving proper hygiene, hydration, protection from sun exposure, and avoiding harmful substances. Skin conditions and diseases range from minor irritations to chronic disorders, emphasizing the importance of regular care and medical attention when needed.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Giloy in Ayurveda - Classical Categorization and Synonyms
Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies
1. Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden Annual 8th Conference of ISPTID, Boston, USA, 29 Septemner to 1 October 2010
7. (Am J Prev Med 2009;37(6):518–523) Eissenberg T, Shihadeh A
8. Khabour et al. Assessment of Genotoxicity of Waterpipe and Cigarette Smoking in Lymphocytes Using the Sister-Chromatid Exchange Assay: A Comparative Study . Environmental and molecular mutagenesis 2010 The results show that waterpipe smoking and cigarette smoking significantly increase the frequencies of SCEs (P < 0.01) compared with those of nonsmokers, indicating the genotoxic effect of tobacco smoking. In addition, frequencies of SCEs were significantly higher among waterpipe smokers compared with CS (P < 0.01), indicating that waterpipe smoking is more genotoxic than cigarette smoking . Moreover, the frequency of SCEs increased with the extent of waterpipe use.
9. Swedish snus Fine ground tobacco leaves predominantly from air-cured dark tobacco Manufactured by a pasteurizing-like heating process (without fermentation as in manufacturing of American snuff), which results in v ery low levels of tobacco-specific nitrosamines and benzo(a)pyrene
14. “ Our argument is that nicotine products should all be regulated rationally in relation to each other, in proportion to their level of hazard , in a system designed to reduce the overall harm caused by nicotine dependence and use.” John Britton, Richard Edwards. Tobacco smoking, harm reduction, and nicotine product Regulation. Lancet 2008; 371: 441–45.
15. HARM 100% 10 0% Nicotine replacement products Snus Traditional cigarettes, Waterpipes Modified cigarettes E-cig ? THE CONTINUUM OF HARM FROM NICOTINE-DELIVERING PRODUCTS Snokless tobacco, e.g. India No tobacco use
16.
17. Recommendations for regulation of smokeless tobacco ● The combined concentration of NNN plus NNK in smokeless tobacco should be limited to 2 μ g/g dry weight of tobacco. ● The concentration of benzo[a]pyrene in smokeless tobacco should be limited to 5 ng/g dry weight of tobacco.
18.
19.
20. ” Although nearly half of the smokers surveyed were willing to purchase an LNSLT product, most were interested in using these products for cessation rather than as a long-term substitute or for dual use with cigarettes.”
21.
Editor's Notes
Prevention of tobacco induced diseases is a very multifaceted issue. I am here going to focus on an aspect that, in recent years, has gained increasing attention, namely the need to help smokers who cannot quit so that they can find other means to minimise their risk for tobacco induced diseases. In order to put these matters in context, we need an overview of goals and objectives in the field of tobacco control.